Mangalam Organics
468.00
-30.55(-6.13%)
Market Cap₹400.82 Cr
PE Ratio17.90
IndustryChemicals
Company Performance:
1D-6.13%
1M-3.01%
6M-15.08%
1Y+15.19%
5Y-48.43%
View Company Insightsright
More news about Mangalam Organics
05Sept 25
Mangalam Organics Reports Q1 FY2021 Results Amid COVID-19 Challenges
Mangalam Organics announced unaudited financial results for Q1 FY2021 ending June 30, 2020. The company's operations were significantly impacted by COVID-19 lockdowns, leading to plant and office shutdowns. A phased resumption of operations began in April 2020. The company's assessment concluded no adjustments were needed in the financial statements. The Board of Directors approved the results, which were submitted to the stock exchange with a Limited Review Report from NGST & Associates.
18Aug 25
Mangalam Organics Secures INR 60 Crore Through Private Placement of NCDs
Mangalam Organics' Board has approved the issuance of Non-Convertible Debentures (NCDs) worth up to INR 60 crores through private placement. The secured, unlisted NCDs offer a 12.50% annual interest rate, with a 36-month tenure and monthly coupon payments. Principal repayment starts after a 15-month moratorium. The NCDs are secured by first pari-passu charge on fixed assets and personal guarantees from key executives.
09Aug 25
Mangalam Organics Reports Strong Q1 Results with 632% PAT Growth
Mangalam Organics, a leading manufacturer of terpene and rosin derivatives, reported robust Q1 FY24 results. Revenue increased by 24.2% to ₹146.55 crores, EBITDA nearly doubled to ₹21.6 crores, and PAT surged by 632.30% to ₹12.23 crores. The company's performance was driven by decreased input costs, improved operational efficiency, and strong market demand. Mangalam Organics operates in B2B (96% of revenue) and B2C segments, focusing on terpene products, synthetic resins, and homecare products. The company is pursuing strategic initiatives including product portfolio expansion, geographical reach extension, e-commerce focus, and exploring new export opportunities in the USA and UK.
08Aug 25
Mangalam Organics Reports Q1 Results, Schedules AGM, and Announces Key Appointments
Mangalam Organics Limited reported robust Q1 financial results with revenue from operations increasing by 24.2% year-over-year to ₹14,655.39 lakhs. Profit before tax grew by over 600% to ₹1,468.70 lakhs. The company scheduled its 43rd AGM for September 16 and announced re-appointment of key directors. New auditor appointments were made, including Internal Auditor, Cost Auditor, and Secretarial Auditor. The company also approved amendments to its Insider Trading Policy. A fire incident occurred at the Camphor Plant on July 16, but the company is working to augment production through Camphor Plant-II.
Mangalam Organics
468.00
-30.55
(-6.13%)
1 Year Returns:+15.19%
Industry Peers